- Right atrial metastasis of a testicular cancer. Achouh, Paul; Grinda, Jean Michel; Emmerich, Joseph; Fabiani, Jean-Noel // European Journal of Cardio-Thoracic Surgery;Mar2012, Vol. 41 Issue 3, p712
The article presents a case study of a 32-year-old patient who underwent surgery for mixed germ cell tumor of the testis followed by chemotherapy through subclavian catheter.
- Long-Term Complications of Chemotherapy for Germ Cell Tumours. Chaudhary, Uzair B.; Haldas, Jason R. // Drugs;2003, Vol. 63 Issue 15, p1565
Testicular cancer is the most common solid tumour among young males aged 15â€“35 years. Cisplatin-based combination chemotherapy has changed the outlook of this disease. Disseminated testicular cancer, once uniformly fatal, now has a cure rate of more than 80% with combination chemotherapy....
- Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT). Bono, J S de; Paul, J; Simpson, A; Anthoney, A; Kirk, D; Underwood, M; Graham, J; Kaye, S B // British Journal of Cancer;8/15/2000, Vol. 83 Issue 4, p426
Between 1991-96, 41 patients were treated in this unit for relapsed non-seminomatous germ cell tumours (NSGCT). Twenty-eight patients had raised markers at relapse: 17 required salvage chemotherapy and post-chemotherapy surgery, 11 only chemotherapy. In addition 9 patients received high dose...
- Acute Vascular Ischemic Events After Cisplatin-Based Combination Chemotherapy for Germ-Cell Tumors of the Testis. Doll, Donald C.; List, Alan F.; Greco, F. Anthony; Hainsworth, John D.; Hande, Kenneth R.; Johnson, David H. // Annals of Internal Medicine;Jul86, Vol. 105 Issue 1, p48
Presents the case of patients with germ-cell tumors of the testis who experienced acute vascular ischemic events after treatment with cisplatin-based combination chemotherapy. Clinical characteristics of the patients; Development of arterial vaso-occlusive complications in patients with malignancy.
- VAB-6 Combination Chemotherapy in Disseminated Cancer of the Testis. Vugrin, Davor; Herr, Harry; Whitmore, Willet F.; Sogani, Pramod C.; Golbey, Robert B. // Annals of Internal Medicine;Jul81, Vol. 95 Issue 1, p59
Presents a study that conducted treatments with the vinblastine, dactinomycin and bleomycin (VAB) -6 protocol on several men with stage III or unresectable stage II malignant germ cell tumors and no previous chemotherapy. Description of the VAB-6 regimen; Evaluations of prior VAB protocols;...
- Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide... Marina, Neyssa M.; Rodman, John H. // JNCI: Journal of the National Cancer Institute;4/6/94, Vol. 86 Issue 7, p544
Presents an assessment of the tolerance for and activity of escalating targeted doses of carboplatin combined with ifosfamide and etoposide (ICE) in children with advanced germ cell tumors or other rare solid tumors for which no standard therapy exists. Response ratings; Pharmacokinetic dose...
- Nodular Pneumonitis after Chemotherapy for Germ Cell Tumors. Trump, Donald L.; Bartel, Eric; Pozniak, Myron // Annals of Internal Medicine;9/1/88, Vol. 109 Issue 5, p431
Presents a study of nodular pneumonitis after chemotherapy for germ cell tumors. Method of the study; Results and discussion; Conclusion.
- Comparative Tolerability of Chemotherapy Regimens for Germ Cell Cancer. Culine, S.; Droz, J-P. // Drug Safety;May2000, Vol. 22 Issue 5, p373
Germ cell tumours, even at an advanced stage, represent a unique model of malignant curable disease since >80% of patients are expected to be cured after appropriate therapy: surgery and radiotherapy in early stages, and chemotherapy and surgery in advanced stages. In advanced stages, serum...
- Testicular germ cell tumor with rhabdomyosarcoma successfully treated by disease-adapted chemotherapy including high-dose chemotherapy: case report and review of the literature. Korfel, A; Fischer, L; Foss, H-D; Koch, H-C; Thiel, E // Bone Marrow Transplantation;10/15/2001, Vol. 28 Issue 8, p787
Treatment and prognosis have not been well characterized in germ cell tumors (GCT) with a malignant nongerm cell component. Patients with a mediastinal tumor, neural or rhabdomyosarcomatous differentiation and distant metastases have the poorest prognosis. We report a rare case of mixed GCT...